(S)-5-((2-((5-Guanidino-1-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)amino)-2-oxoethyl)amino)-5-oxopentanoic acid

Catalog No. :
ACNEUP284
CAS No. :
65147-16-2
Molecular Formula :
C23H30N6O7
Molecular Weight :
502.53

IUPAC Name:(S)-5-((2-((5-guanidino-1-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)amino)-2-oxoethyl)amino)-5-oxopentanoic acid

(S)-5-((2-((5-Guanidino-1-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)amino)-2-oxoethyl)amino)-5-oxopentanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$1077.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-5-((2-((5-Guanidino-1-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)amino)-2-oxoethyl)amino)-5-oxopentanoic acid
IUPAC Name(S)-5-((2-((5-guanidino-1-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)amino)-2-oxoethyl)amino)-5-oxopentanoic acid
Molecular FormulaC23H30N6O7
Molecular Weight502.53
SMILESCC1=CC(=O)OC2=CC(NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CCCC(=O)O)=CC=C12
InChI KeyIBJAOCSITSPKFU-INIZCTEOSA-N
SynonymGLUTARYL-GLY-ARG-7-AMIDO-4-METHYLCOUMARIN;GLUTARYL-GLY-ARG-7-AMINO-4-METHYLCOUMARIN;GLUTARYL-GLY-ARG-AMC;GLUTARYLGLYCYL-L-ARGININE 4-METHYLCOUMARYL-7-AMIDE;GLUTARYLGLYCYL-L-ARGINYL-4-METHYLCOUMARYL-7-AMIDE;GLT-GLY-ARG-MCA;N-Glutaryl-Gly-Arg-7-Amido-4-Methylcoumarin;GLUTARYL-GR-AMC
CAS No.65147-16-2

Synthetic Route by SureRoute

1. ACNEUP284 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNEUP284 route product structure diagram
    ACNEUP28465147-16-2
Inquiry

2. ACNEUP284 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNEUP284 route product structure diagram
    ACNEUP28465147-16-2
Inquiry

Comments (0)